Rebecca March
Internal Medicine · Olympia, WANPI 1407261936
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,320 of the $6,699 with a category attached, or 79.4%. It is spread thinly across 39 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,530 and has fallen 82.0% since, to $635 in 2022. Among internal medicine clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 341 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$1K
- Amgen$664
- AbbVie$443
- Novo Nordisk$408
- Lilly USA, LLC$404
- AstraZeneca$386
- plus $3K from 33 others
What the payments were for
- Travel & lodging$1,12217%
- Food & beverage$5,32079%
- Education$2574%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 4 | $1,472 |
| Amgen(2 entities) | 31 | $664 |
| AbbVie(2 entities) | 28 | $443 |
| Novo Nordisk | 46 | $408 |
| Lilly USA, LLC | 36 | $404 |
| AstraZeneca | 27 | $386 |
| Johnson & Johnson | 22 | $306 |
| Pfizer | 16 | $285 |
| Novartis | 18 | $285 |
| Sanofi-aventis U.S. LLC | 17 | $256 |
| Astellas Pharma US Inc | 5 | $245 |
| Boehringer Ingelheim | 12 | $216 |
| Corcept Therapeutics | 9 | $145 |
| Insulet Corporation | 6 | $145 |
| GSK | 8 | $136 |
| Merck | 8 | $118 |
| Bayer | 1 | $80 |
| Teva Pharmaceuticals USA, Inc. | 5 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $73 |
| Amarin Pharma, Inc. | 4 | $66 |
| Abbott | 3 | $56 |
| Medtronic(2 entities) | 3 | $55 |
| Lifescan, Inc. | 3 | $50 |
| Dexcom, Inc. | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Mannkind Corporation | 2 | $33 |
| Seqirus USA Inc | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 2 | $27 |
| Bausch Health US, LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Mylan Specialty L.p. | 1 | $18 |
| Tandem Diabetes Care, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Genentech USA, Inc. | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DALVANCE$128
How this compares
$6,699 in reported general payments places this provider in the 95th percentile of 2,038 internal medicine providers in Washington.
Other internal medicine in Olympia
- Shawna PurcellOlympia$294K
- Eric KleinOlympia$23K
- Curtis ReinkeOlympia$14K
- Sabrina BenjaminOlympia$7K
- Peter ShalitSeattle$1M
- Lawrence LoebBellevue$784K
- Scott RamseySeattle$230K
- Michael CairnsSeattle$144K
- Peiqing QianSeattle$117K
- Alan KellySpokane Valley$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.